Health
Researchers launch randomized, placebo-controlled clinical trial of pulmozyme in COVID-19 patients – News-Medical.Net
Researchers at Boston Children’s Hospital and Brigham and Women’s Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventil…
Researchers at Boston Children’s Hospital and Brigham and Women’s Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
The study aims to enroll 60 adults and children (over age 3) admitted to intensive care units.
Dornase alfa, also called DNase 1, is FDA-approved for patients with cystic fibrosis, to break up thick mucus secretions and prevent lung…
-
Noosa News21 hours agoTragedy as young footballer found dead on Pacific Motorway, south of Tweed Heads, after cars crash into unoccupied motorbike
-
Noosa News23 hours agoBrisbane news live: Accused wife killer to answer curfew-breach charge
-
Noosa News23 hours agoSeller disclosure a game changer for Qld – Proctor
-
Noosa News15 hours agoMillions of pieces of evidence collected in Brisbane Russian spy case